128 related articles for article (PubMed ID: 37962326)
1. Metabolite signature of diabetes remission in individuals with obesity undergoing weight loss interventions.
Thaker VV; Kwee LC; Chen H; Bahnson J; Ilkayeva O; Muehlbauer MJ; Wolfe B; Purnell JQ; Pi-Sunyer X; Newgard CB; Shah SH; Laferrère B;
Obesity (Silver Spring); 2024 Feb; 32(2):304-314. PubMed ID: 37962326
[TBL] [Abstract][Full Text] [Related]
2. Roux-en-Y gastric bypass surgery, but not calorie restriction, reduces plasma branched-chain amino acids in obese women independent of weight loss or the presence of type 2 diabetes.
Lips MA; Van Klinken JB; van Harmelen V; Dharuri HK; 't Hoen PA; Laros JF; van Ommen GJ; Janssen IM; Van Ramshorst B; Van Wagensveld BA; Swank DJ; Van Dielen F; Dane A; Harms A; Vreeken R; Hankemeier T; Smit JW; Pijl H; Willems van Dijk K
Diabetes Care; 2014 Dec; 37(12):3150-6. PubMed ID: 25315204
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of 1-year outcomes between Roux-en-Y gastric bypass and sleeve gastrectomy with Roux-en-Y duodenojejunal bypass in the patients of obesity with type 2 diabetes mellitus].
Liang H; Si YM; Lin SB; Shen JJ; Guan W
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Nov; 26(11):1051-1057. PubMed ID: 37974350
[No Abstract] [Full Text] [Related]
4. Effect of Roux-en-Y Gastric Bypass on Remission of T2D: Medium-Term Follow-up in Chinese Patients with Different BMI Obesity Class.
Zhang H; Han X; Yu H; Di J; Zhang P; Jia W
Obes Surg; 2017 Jan; 27(1):134-142. PubMed ID: 27312346
[TBL] [Abstract][Full Text] [Related]
5. Reduction of Plasma BCAAs following Roux-en-Y Gastric Bypass Surgery Is Primarily Mediated by FGF21.
Shah H; Kramer A; Mullins CA; Mattern M; Gannaban RB; Townsend RL; Campagna SR; Morrison CD; Berthoud HR; Shin AC
Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049555
[TBL] [Abstract][Full Text] [Related]
6. Diabetes and branched-chain amino acids: What is the link?
Bloomgarden Z
J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
[TBL] [Abstract][Full Text] [Related]
7. Glycemic control and BMI changes after endoscopic implantation of a duodenojejunal bypass liner compared with laparoscopic Roux-en-Y gastric bypass surgery: a propensity score matching analysis.
Günthert SJ; Aksan A; Schröder O; Meyer G; Hausmann J; Stein J; Stier C
Surg Endosc; 2022 Aug; 36(8):5979-5985. PubMed ID: 35378626
[TBL] [Abstract][Full Text] [Related]
8. Changes in bone quality after Roux-en-Y gastric bypass: A prospective cohort study in subjects with and without type 2 diabetes.
Blom-Høgestøl IK; Mala T; Kristinsson JA; Brunborg C; Gulseth HL; Eriksen EF
Bone; 2020 Jan; 130():115069. PubMed ID: 31593823
[TBL] [Abstract][Full Text] [Related]
9. "Dual-remission" after Roux-en-Y gastric bypass surgery: Glycemic variability cannot always be improved in Chinese obese patients with type 2 diabetes.
Yu H; Zhou J; Bao Y; Pin Zhang ; Lu W; Jia W
Surg Obes Relat Dis; 2016 Aug; 12(7):1312-1319. PubMed ID: 26823091
[TBL] [Abstract][Full Text] [Related]
10. Variation in HbA1c in Patients with Obesity and type 2 Diabetes Mellitus 12 months after Laparoscopic One-Anastomosis Gastric Bypass and Laparoscopic Roux-en-Y Gastric Bypass: a Retrospective Matched Cohort Study.
van Rijswijk AS; Meijnikman AS; Mikdad S; Hutten BA; van der Peet DL; van de Laar AW; Gerdes VEA; de Brauw M
Obes Surg; 2024 Mar; 34(3):940-946. PubMed ID: 38321253
[TBL] [Abstract][Full Text] [Related]
11. Preserved Insulin Secretory Capacity and Weight Loss Are the Predominant Predictors of Glycemic Control in Patients With Type 2 Diabetes Randomized to Roux-en-Y Gastric Bypass.
Nguyen KT; Billington CJ; Vella A; Wang Q; Ahmed L; Bantle JP; Bessler M; Connett JE; Inabnet WB; Thomas A; Ikramuddin S; Korner J
Diabetes; 2015 Sep; 64(9):3104-10. PubMed ID: 25901097
[TBL] [Abstract][Full Text] [Related]
12. Type 2 diabetes remission after Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG), and one anastomosis gastric bypass (OAGB): results of the longitudinal assessment of bariatric surgery study.
Moradi M; Kabir A; Khalili D; Lakeh MM; Dodaran MS; Pazouki A; Kermansaravi M; Alibeigi P; Moazenzadeh H; Abdolhosseini MR; Eghbali F; Baradaran HR
BMC Endocr Disord; 2022 Oct; 22(1):260. PubMed ID: 36289529
[TBL] [Abstract][Full Text] [Related]
13. Early metabolomic, lipid and lipoprotein changes in response to medical and surgical therapeutic approaches to obesity.
Angelidi AM; Kokkinos A; Sanoudou D; Connelly MA; Alexandrou A; Mingrone G; Mantzoros CS
Metabolism; 2023 Jan; 138():155346. PubMed ID: 36375643
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Weight Loss Results, Remission of Comorbidities and Nutritional Deficiencies of Sleeve Gastrectomy (SG), Roux-En-Y Gastric Bypass (RYGB) and One-Anastomosis Gastric Bypass (OAGB) on Type 2 Diabetic (T2D) Patients.
Castro MJ; Jimenez JM; Carbajo MA; Lopez M; Cao MJ; Garcia S; Ruiz-Tovar J
Int J Environ Res Public Health; 2020 Oct; 17(20):. PubMed ID: 33092117
[TBL] [Abstract][Full Text] [Related]
15. Relationships between type 2 diabetes remission after gastric bypass and different weight loss metrics: arguments against excess weight loss in metabolic surgery.
van de Laar AW; de Brauw LM; Meesters EW
Surg Obes Relat Dis; 2016 Feb; 12(2):274-82. PubMed ID: 26476492
[TBL] [Abstract][Full Text] [Related]
16. Comparison of early type 2 diabetes improvement after gastric bypass and sleeve gastrectomy: medication cessation at discharge predicts 1-year outcomes.
Heshmati K; Harris DA; Aliakbarian H; Tavakkoli A; Sheu EG
Surg Obes Relat Dis; 2019 Dec; 15(12):2025-2032. PubMed ID: 31711946
[TBL] [Abstract][Full Text] [Related]
17. Effect of Roux-en-Y gastric bypass on the remission of type 2 diabetes: a 3-year study in Chinese patients with a BMI <30 kg/m
Di J; Zhang H; Yu H; Zhang P; Wang Z; Jia W
Surg Obes Relat Dis; 2016 Aug; 12(7):1357-1363. PubMed ID: 27387699
[TBL] [Abstract][Full Text] [Related]
18. Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity.
Hall TC; Pellen MG; Sedman PC; Jain PK
Obes Surg; 2010 Sep; 20(9):1245-50. PubMed ID: 20524158
[TBL] [Abstract][Full Text] [Related]
19. Factors Mediating Type 2 Diabetes Remission and Relapse after Gastric Bypass Surgery.
Pessoa BM; Browning MG; Mazzini GS; Wolfe L; Kaplan A; Khoraki J; Campos GM
J Am Coll Surg; 2020 Jan; 230(1):7-16. PubMed ID: 31672669
[TBL] [Abstract][Full Text] [Related]
20. Comparative Safety and Effectiveness of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy for Weight Loss and Type 2 Diabetes Across Race and Ethnicity in the PCORnet Bariatric Study Cohort.
Coleman KJ; Wellman R; Fitzpatrick SL; Conroy MB; Hlavin C; Lewis KH; Coley RY; McTigue KM; Tobin JN; McBride CL; Desai JR; Clark JM; Toh S; Sturtevant JL; Horgan CE; Duke MC; Williams N; Anau J; Horberg MA; Michalsky MP; Cook AJ; Arterburn DE; Apovian CM;
JAMA Surg; 2022 Oct; 157(10):897-906. PubMed ID: 36044239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
